Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2004
04/22/2004US20040077626 In vivo stability; very low metabolism rate
04/22/2004US20040077619 Calcium receptor modulating agents
04/22/2004US20040077515 Fluorescent whitening agents for natural and synthetic materials; water solubility
04/22/2004DE10247226A1 New heteroaryl-substituted carboxylic acid amide derivatives, useful as factor Xa and factor VIIa inhibitors for e.g. treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors
04/22/2004CA2501611A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
04/22/2004CA2501575A1 Inhibitors of fatty acid amide hydrolase
04/22/2004CA2501529A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/22/2004CA2501520A1 Sulfonamides having antiangiogenic and anticancer activity
04/22/2004CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives
04/22/2004CA2501239A1 R-nsaid esters and their use
04/22/2004CA2500582A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
04/22/2004CA2499642A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
04/22/2004CA2499105A1 Antimicrobial 1-aryl dihydropyridone compounds
04/22/2004CA2498658A1 Dibenzoxazepine
04/21/2004EP1411047A1 Intercalators having affinity for DNA and methods of use
04/21/2004EP1411046A1 QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF−PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME
04/21/2004EP1410822A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents
04/21/2004EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth
04/21/2004EP1409484A1 Substituted benzo-nitro-heterocycles
04/21/2004EP1409477A1 Piperidine derivatives as nmda receptor antagonists
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1409465A2 Oxazolidinone derivatives as antimicrobials
04/21/2004EP1409464A1 Oxazolidinone derivatives as potential antimicrobials
04/21/2004EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1408962A1 Substituted isoindoles and the use thereof
04/21/2004EP1408950A2 Methods of treating cytokine mediated diseases
04/21/2004EP1149094B1 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
04/21/2004EP0973750B1 Substituted benzimidazoles and their use for treating retroviral infection
04/21/2004EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
04/21/2004EP0900795B1 Benzene derivatives substituted by heterocycles and herbicides
04/21/2004CN1491222A Piperidinee derivatives as neurokinin/antagonists
04/21/2004CN1490318A Oxynitride helerocyclic compounds and preparation thereof
04/21/2004CN1146564C Antibiotic sultam and sultone drived oxazolidiones
04/21/2004CN1146563C Piperidinylmethyloxazolidinone derivative
04/21/2004CN1146561C Pyrimidine derivatives exhibiting antitumor activity
04/21/2004CN1146560C Substituted benzoylpyrazoles as herbicides
04/21/2004CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof
04/21/2004CN1146550C Halogenated pyrimidines and its application as method for reducing parasite
04/21/2004CN1146548C Isoxazolyl-and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/21/2004CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound
04/21/2004CN1146416C Use of H+, K+-ATPase inhibitor in treatment of nasal polyps
04/20/2004US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent
04/20/2004US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides
04/20/2004US6723724 Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
04/20/2004US6723718 Substituted α, β-anellated butyrolactones
04/15/2004WO2004031401A2 Novel tyrosine kinases inhibitors
04/15/2004WO2004031294A1 Synergistic uv absorber combination
04/15/2004WO2004031181A1 Sulfonamide derivatives as antipsychotic agents
04/15/2004WO2004031176A2 Delta1 pyrrolines used as pesticides
04/15/2004WO2004031161A1 Neurologically-active compounds
04/15/2004WO2004031158A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors
04/15/2004WO2004030637A2 Treatment of obesity and other disorders associated with excessive food intake
04/15/2004WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
04/15/2004WO2003022844A9 Synthesis of epothilones intermediates thereto and analogues thereof
04/15/2004WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
04/15/2004US20040073044 Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
04/15/2004US20040073036 Substituted alkyl amido piperidines
04/15/2004US20040073029 Oxygen or sulfur containing heteroaromatics as factor Xa inhibitors
04/15/2004US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
04/15/2004US20040072881 Dietetics; osteoporosis; muscular disorders
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072873 Therapy for drug resistant infections
04/15/2004US20040072871 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them
04/15/2004US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents
04/15/2004US20040072849 Dioxanes and uses thereof
04/15/2004US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
04/15/2004US20040072841 Topical administration of oxazolidinones for transdermal delivery
04/15/2004US20040072840 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
04/15/2004US20040072828 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
04/15/2004US20040072819 Benzoxazepine compounds, their production and use
04/15/2004US20040072692 4-trifluoromethylpyrazolyl-substituted pyridines and pyrimidines
04/14/2004EP1407782A1 Preventives/remedies for organ functional disorders and organ dysfunction
04/14/2004EP1407770A1 Tgf-beta superfamily production/secretion promoter
04/14/2004EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
04/14/2004EP1406897A2 Compounds
04/14/2004EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
04/14/2004EP1406893A1 Pyrrolidine bicyclic compounds
04/14/2004EP1406891A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
04/14/2004EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin
04/14/2004EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
04/14/2004EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/14/2004EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
04/14/2004EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/14/2004EP1406628A1 Tetrahydroquinoline derivatives
04/14/2004EP1406620A1 Vinyl phenyl derivatives as glk activators
04/14/2004EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury
04/14/2004EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
04/14/2004EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
04/14/2004EP1274426B1 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
04/14/2004EP1189583A4 Indole derivatives
04/14/2004EP1102757B1 Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators
04/14/2004EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
04/14/2004EP0921800B1 Substituted biphenyl isoxazole sulfonamides
04/14/2004EP0706515B1 Intercalators having affinity for dna and methods of use
04/14/2004CN1489587A Proces for synthesis of 5-(4-fluorophenyl)-1-[2R, 4R]-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxypic acid phenylamide
04/14/2004CN1489582A Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
04/14/2004CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives
04/14/2004CN1489458A Inhibitors against the production and releaseof inflammator cytokines